Our results also suggest that in acquiring hyper-inflammatory capacity, ICAM-1 elevation and TNF-α and IL-1β secretion are more likely to be accompanying rather than necessary events in ATRA-induced APL differentiation. The gene discussed is ICAM1; the disease is acute promyelocytic leukemia.